2m 2m 2m 2m 2m 2m 2m
Insmed (INSM)
NASDAQ
$111.70+$3.11 (+2.86%)
Price as of Oct 02, 2026 4:22 PM EDT- $23.7BMarket Cap
- -28.93%1-Year Change
- BiotechnologyIndustry
Insmed (INSM)
$111.70+$3.11 (+2.86%)
Earnings Score
Valuation | INSM | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | -0 | ||
Growth | 0 | ||
Low Earnings Volatility | 2 |
Momentum Score
Valuation | INSM | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | 13.97% | ||
12-Month Momentum | -17.50% | ||
3-Month Risk Adjusted Momentum | 37.85% | ||
12-Month Risk Adjusted Momentum | -28.51% |
True Yield
Valuation | INSM | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | N/A | ||
Net Debt Paydown Yield | -0.004% |
Financial Health Score
Valuation | INSM | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 6 |